Figure 2.
Risk of relapse among 108 Chinese women with primary breast diffuse large B‐cell lymphoma. Cumulative risk at all sites (A), nodal sites (B), extranodal sites (C), breast (D), and CNS (E) according to the use of rituximab
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.